Travere Therapeutics, Inc.

TVTX· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$54.95-1.68%

2026-08-03

Financials

Valuation Metrics

Travere Therapeutics, Inc.'s Market Cap is $5.11B. At end of 2025 it was $3.45B. Ranked #1383 of 3,112 in US market (top 44%), #477 of 1,445 on NASDAQ (top 33%), #79 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 29%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$5.11B	US#1,383/3,112 Sec#79/269
Revenue	$536M	US#2,316/3,112 Sec#78/269
Net Income	$-21M	US—/3,112 Sec—/269
Total Assets	$555M	US#2,703/3,112 Sec#142/269
Net Assets	$99M	US#2,881/3,112 Sec#230/269
Value
P/B	51.76x	US#2,929/3,112 Sec#250/269
P/S	9.53x	US#2,635/3,112 Sec#117/269
EV/EBITDA	139.06x	US#2,453/3,112 Sec#86/269
FCF Yield	-0.04%	US—/3,112 Sec—/269
Profitability
ROE	-21.70%	US#2,540/3,112 Sec#105/269
ROA	-3.86%	US#2,478/3,112 Sec#90/269
Op. Margin	-10.64%	US#2,635/3,112 Sec#99/269
Revenue Growth	55.63%	US#267/3,112 Sec#51/269
Financial Health
Debt Ratio	462.34%	US#2,352/3,112 Sec#233/269
Total Debt	$328M	US#2,003/3,112 Sec#72/269
FCF	$-2M	US#2,282/3,112 Sec#86/269
Cash	$78M	US#2,350/3,112 Sec#191/269
Current Ratio	3.13x	US#767/3,112 Sec#191/269
Net Debt/EBITDA	6.47x	US#2,209/3,112 Sec#87/269
Performance
1Y Return	251.57%	US#73/3,112 Sec#23/269
1M Return	-3.46%	US#2,080/3,112 Sec#110/269
From 52W High	-8.57%	US#917/3,112 Sec#44/269
1Y MDD	-33.49%	US#1,607/3,112 Sec#103/269
Trading
Volume	1,831,776 shares	US#964/3,112 Sec#86/269
Trading Value	$100M	US#904/3,112 Sec#55/269
Per Share
EPS	$-0.56	US—/3,112 Sec—/269
BPS	$1.27	US#2,587/3,112 Sec#194/269